correction
A previous version of this article incorrectly stated that Dionysus Digital Health received a $6 billion grant from the Department of Defense. It received $6 million.
Postpartum depression is a leading cause of maternal death, but its diagnosis and treatment is spotty at best, negligent at worst.
Now San Diego-based start-up Dionysus Digital Health is pitching a blood test to check for the condition, even before symptoms appear. The company says it has pinpointed a gene linking a person’s moods more closely to hormonal changes. The test uses machine learning to compare epigenetics — how genes are expressed — in your blood sample with benchmarks developed during a decade of research into pregnant people who did and didn’t develop postpartum depression.
source: https://www.washingtonpost.com/technology/2024/04/29/ai-healthcare-postpartum-depression-screening/
